Early-life B-glucan exposure enhances disease resilience of broiler chickens to a natural Clostridium perfringens infection

Necrotic enteritis (NE) is an economically important disease in poultry. Colonization by the opportunistic pathogen C. perfringens occurs early after hatch and induces host immune tolerance, which allows it to persist as part of the bird's commensal microflora. B-glucan, a yeast cell wall component, is well characterized for its immunomodulatory capacity, and is a strong driver of innate immune memory. In this study, we assessed the effectiveness of B-glucan to reduce severity of NE, when co-administered with heat-killed C. perfringens via intra-abdominal route at day 1 of age. We found that this early-life exposure in the presence of B-glucan did not reduce intestinal C. perfringens loads or lesion severity during a subsequent NE outbreak. However, it improved ileal morphology, prevented liver and spleen weight decline, and preserved feed efficiency in challenged birds. Molecular analyses revealed metabolic changes consistent with innate immune memory. Together, our results suggest that B-glucan can reduce the negative impacts of NE by influencing the context in which C. perfringens is first encountered.

Automated summary

The study found that B-glucan can reduce the negative impacts of necrotic enteritis in poultry by influencing the context in which C. perfringens is first encountered.